Eptinezumab in Adults With Migraine and Medication Overuse Headache (Sunlight)

NCT04772742 PHASE3 COMPLETED

This study evaluates the efficacy of eptinezumab to prevent migraine and headache in patients with the combined diagnosis of migraine and medication overuse headache

Details

Lead sponsor	H. Lundbeck A/S
Phase	PHASE3
Status	COMPLETED
Enrolment	193
Start date	Wed Feb 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Sep 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Migraine
• Medication Overuse Headache

Interventions

• Placebo
• Eptinezumab

Countries

Georgia, Taiwan, South Korea, China, Spain